You are here

drug launches

Prepping for a rapid-fire launch, Kite Pharma gets a pass from FDA on axi-cel panel review

Prepping for a rapid-fire launch, Kite Pharma gets a pass from FDA on axi-cel panel review

Endpoints

Flag link:

Sanofi's eczema rollout Dupixent hits blockbuster launch trajectory as earnings beat

Sanofi's eczema rollout Dupixent hits blockbuster launch trajectory as earnings beat

Fierce Pharma

Flag link:

For Biogen's Spinraza launch, things are looking up on the coverage front: analyst

For Biogen's Spinraza launch, things are looking up on the coverage front: analyst

Fierce Pharma

spinal muscular atrophy

Flag link:

Parkinson's drug Xadago launches in US

Parkinson's drug Xadago launches in US

BioPharma Dive

Parkinson's Disease

Flag link:

Just what Sanofi and Regeneron wanted: A Dupixent rollout so zippy, it's fueling bigger sales forecasts

Just what Sanofi and Regeneron wanted: A Dupixent rollout so zippy, it's fueling bigger sales forecasts

Fierce Pharma

Flag link:

New GlaxoSmithKline CEO wants fewer, bigger new drug launches

New GlaxoSmithKline CEO wants fewer, bigger new drug launches

Yahoo/Reuters

Flag link:

Biogen touts stronger-than-expected rollout for Spinraza

Biogen touts stronger-than-expected rollout for Spinraza

BioPharma Dive

spinal muscular atrophy

Flag link:

Improving outcomes start before drug launchImproving outcomes start before drug launch

Improving outcomes start before drug launchImproving outcomes start before drug launch

BioPharma Dive

clinical outcomes

Flag link:

Chasing a big payday, new drugmakers slightly favor solo launches: Report

Chasing a big payday, new drugmakers slightly favor solo launches: Report

Fierce Pharma

Flag link:

Payer snubs PTC's Emflaza, signaling pricing trouble ahead of launch

Payer snubs PTC's Emflaza, signaling pricing trouble ahead of launch

Fierce Pharma

PTC Therapeutics

Duchenne Muscular Dystrophy

Flag link:

Pfizer wins TRO against ex-marketing manager accused of stealing launch plans

Pfizer wins TRO against ex-marketing manager accused of stealing launch plans

Fierce Pharma

restraining order

Flag link:

Synergy preps for Trulance launch with competitive pricing, experienced GI reps

Synergy preps for Trulance launch with competitive pricing, experienced GI reps

Fierce Pharma

Synergy Pharmaceuticals

Flag link:

Amgen's Repatha wins in outcomes trial, but is the score high enough?

Amgen's Repatha wins in outcomes trial, but is the score high enough?

Fierce Pharma

Flag link:

This Was, Unquestionably, the Most Disappointing Drug Launch of 2016

This Was, Unquestionably, the Most Disappointing Drug Launch of 2016

Motley Fool

Flag link:

Biotech Stocks: What to Watch in 2017

Biotech Stocks: What to Watch in 2017

Motley Fool

Gilead Sciences

Ionis Pharmaceuticals

Flag link:

What puts a new drug launch in line for victory? Ask Gilead, Biogen and J&J

What puts a new drug launch in line for victory? Ask Gilead, Biogen and J&J

Fierce Pharma

Gilead Sciences

Flag link:

Could Pfizer's at-risk Inflectra launch set a biosimilars precedent for Amgen, Novartis?

Could Pfizer's at-risk Inflectra launch set a biosimilars precedent for Amgen, Novartis?

Fierce Pharma

Flag link:

MannKind - 2 Months Into Relaunch Of Afrezza - Where Things Stand And What To Expect

MannKind - 2 Months Into Relaunch Of Afrezza - Where Things Stand And What To Expect

Seeking Alpha

Flag link:

Reimbursement rather than Brexit more likely to impact how drugmakers order global launches

Reimbursement rather than Brexit more likely to impact how drugmakers order global launches

Medical Marketing and Media

global launches

Flag link:

MannKind turns to digital, social media to spread the word on Afrezza's relaunch

MannKind turns to digital, social media to spread the word on Afrezza's relaunch

Fierce Pharma

Flag link: